CXL146, a Novel 4h-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug Resistant Cancer Cells

Molecular Pharmacology- United States

doi 10.1124/mol.119.118745

Full Text

Abstract

Available in

Categories

Molecular Medicine

Date

April 10, 2020

Authors

Abderrahmane Tagmounti

Christopher Vulpe

Kavitha Chandagirikoppal Vijendra

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Crystal Structure of the Calcium ATPase SERCA in Complex to a Novel Anti-Cancer Agent That Targets Multidrug-Resistant Leukemia

Biophysical Journal

English

Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS

Multidisciplinary

English

Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Research

English

A Novel Synthetic Dihydroindeno[1,2-B] Indole Derivative (LS-2-3j) Reverses ABCB1- And ABCG2-Mediated Multidrug Resistance in Cancer Cells

Organic Chemistry

Molecular Medicine

Analytical Chemistry

Theoretical Chemistry

Pharmaceutical Science

English

6,8-Diiodo-4-Oxo-4h-Chromene-3-Carbaldehyde

Acta Crystallographica Section E Structure Reports Online

English

Silver Nanoweapons: A Novel Tool Against Multidrug Resistant Bacteria

Biosciences Biotechnology Research Asia

English

Isolation and Characterization of Hepatitis C Virus Resistant to a Novel Phenanthridinone Derivative

Antiviral Chemistry and Chemotherapy

English

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro

Journal of Translational Medicine

Molecular Biology

English

Phosphosulindac (OXT-328) Selectively Targets Breast Cancer Stem Cells in Vitro and in Human Breast Cancer Xenografts

Molecular Medicine

Developmental Biology

English